- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 84-98 of
169 results
1036 Exhibit: Rajkumar, SV, et al, Combination therapy with lenalidomide plus dexa...
Document
IPR2018-01714, No. 1036-36 Exhibit - Rajkumar, SV, et al, Combination therapy with lenalidomide plus dexamethasone RevDex for newly diagnosed myeloma, Blood, 1064050 4053 2005 (P.T.A...
|
|
Cite Document
1010 Exhibit: Corral Kaplan, Immunomodulation by thalidomide and thalidomide an...
Document
IPR2018-01714, No. 1010-10 Exhibit - Corral Kaplan, Immunomodulation by thalidomide and thalidomide analogues, Ann Rheum Dis, 58 I107 I113 1999 (P.T.A.B. Sep. 12, 2018)
|
|
Cite Document
1051 Exhibit: US Food and Drug Administration, List of Orphan Designations and A...
Document
IPR2018-01714, No. 1051-51 Exhibit - US Food and Drug Administration, List of Orphan Designations and Approvals, available at httpswwwaccessdatafdagovscriptsopdlistingoopd published on...
|
|
Cite Document
1055 Exhibit: Declaration of James L Mullins, PhD Part 2 of 5
Document
IPR2018-01714, No. 1055-56 Exhibit - Declaration of James L Mullins, PhD Part 2 of 5 (P.T.A.B. Sep. 12, 2018)
|
|
Cite Document
1045 Exhibit: Gandhi, AK, Dexamethasone Synergizes with Lenalidomide to Inhibit...
Document
IPR2018-01714, No. 1045-45 Exhibit - Gandhi, AK, Dexamethasone Synergizes with Lenalidomide to Inhibit Multiple Myeloma Tumor Growth, But Reduces Lenalidomide Induced Immunomodula...
|
|
Cite Document
1024 Exhibit: Cytovene¿¿ IV, Physicians Desk Reference 2623 2629 54th ed 2000
Document
IPR2018-01714, No. 1024-24 Exhibit - Cytovene¿¿ IV, Physicians Desk Reference 2623 2629 54th ed 2000 (P.T.A.B. Sep. 12, 2018)
|
|
Cite Document
1046 Exhibit: Malpas, Management of Multiple Myeloma, Br Med J, 2163 165 1969
Document
IPR2018-01714, No. 1046-46 Exhibit - Malpas, Management of Multiple Myeloma, Br Med J, 2163 165 1969 (P.T.A.B. Sep. 12, 2018)
|
|
Cite Document
1021 Exhibit: Gordon et al, A Phase I Trial of Recombinant Human Interleukin 11 Ne...
Document
IPR2018-01714, No. 1021-21 Exhibit - Gordon et al, A Phase I Trial of Recombinant Human Interleukin 11 Neumega rhIL 11 Growth Factor in Women With Breast Cancer Receiving Chemotherap...
|
|
Cite Document
1007 Exhibit: Durie Stepan, Efficacy of Low Dose Thalidomide in Multiple Myeloma,...
Document
IPR2018-01714, No. 1007-7 Exhibit - Durie Stepan, Efficacy of Low Dose Thalidomide in Multiple Myeloma, Electronic Journal of Oncology, 11 8 2000 (P.T.A.B. Sep. 12, 2018)
|
|
Cite Document
1015 Exhibit: Palumbo, et al, Low dose thalidomide plus dexamethasone is an effec...
Document
IPR2018-01714, No. 1015-15 Exhibit - Palumbo, et al, Low dose thalidomide plus dexamethasone is an effective salvage therapy for advanced myeloma, Hematologica, 864399 403 April 2001 (P...
|
|
Cite Document
1048 Exhibit: Oken et al, Contribution of Prednisone to the Effectiveness of Hexam...
Document
IPR2018-01714, No. 1048-48 Exhibit - Oken et al, Contribution of Prednisone to the Effectiveness of Hexamethylmelamine in Multiple Myeloma, Cancer Treatment Reports, 71807 811 1987 (P.T...
|
|
Cite Document
1005 Exhibit: Tramontana et al, Thalidomide Treatment Reduces Tumor Necrosis F...
Document
IPR2018-01714, No. 1005-5 Exhibit - Tramontana et al, Thalidomide Treatment Reduces Tumor Necrosis Factor ¿¿ Production and Enhances Weight Gain in Patients with Pulmonary Tuberculosis...
|
|
Cite Document
1055 Exhibit: Declaration of James L Mullins, PhD Part 5 of 5
Document
IPR2018-01714, No. 1055-59 Exhibit - Declaration of James L Mullins, PhD Part 5 of 5 (P.T.A.B. Sep. 12, 2018)
|
|
Cite Document
1020 Exhibit: Gebbia et al, Single agent 2,2 difluorodeoxycytidine in the treatment ...
Document
IPR2018-01714, No. 1020-20 Exhibit - Gebbia et al, Single agent 2,2 difluorodeoxycytidine in the treatment of metastatic urothelial carcinoma a phase II study, La Clinica Terapeutica, 150111 15...
|
|
Cite Document
1060 Exhibit: Orange Book Approved Drug Products with Therapeutic Equivalence...
Document
IPR2018-01714, No. 1060-64 Exhibit - Orange Book Approved Drug Products with Therapeutic Equivalence Evaluations, Patent and Exclusivity for N021880 (P.T.A.B. Sep. 12, 2018)
|
|
Cite Document
